Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112778252A reveals a novel N-doped carbon bimetallic catalyst for converting o-xylene to phthalide with high selectivity, offering safer and cost-effective production.
Patent CN110590721B details a cost-effective method for producing 2,5-furandicarboxylic acid diesters using earth-abundant catalysts, offering significant supply chain advantages.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.
Patent CN110777125B details a novel Y127W mutant enzyme for high-concentration synthesis of chiral piperidine intermediates, offering significant cost reduction in API manufacturing.
Patent CN103319455B reveals a novel route for high-purity Strontium Ranelate. Discover cost-effective catalytic strategies and scalable purification for API manufacturing.
Patent CN113322291A details an enzymatic route for high-purity chiral amino alcohols, offering cost-effective solutions for veterinary antibiotic manufacturing.
Patent CN111094557B details novel ADH mutants enabling cost-effective, high-ee biocatalytic synthesis of chiral biaryl alcohols for antihistamine drugs.
Patent CN113173894A enables green continuous production of tetrahydrofuran-3-one. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105603028B reveals dual-enzyme process for glutathione and adenylate. Reduces ATP cost and simplifies purification for reliable supply chain partners.
Novel phase-transfer catalysis process for anti-inflammatory intermediates. Reduces dialkylation impurities and simplifies purification for cost-effective API manufacturing.
Novel silver-catalyzed route for benzothiazine intermediates ensures high purity and cost-effective manufacturing for pharmaceutical supply chains globally. This method offers substantial operational advantages.
Patent CN103360341B reveals novel tert-leucine derivatives enabling high-selectivity organocatalysis. This technology offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN103570617B reveals high-purity oxidation method. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Patent CN111662260B reveals a 7-step synthesis of saffloneoside. Offers stable intermediates and scalable routes for cerebral ischemia drug development.
Patent CN112941114A reveals high-purity enzymatic route for chiral triols. Reduces production cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN115057840B details a visible light-promoted synthesis of 3-acyl coumarins. This method offers cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN114381441B reveals imine reductase catalysis for optical pure chiral amino alcohols. Offers mild conditions and high stereoselectivity for pharmaceutical supply chains.
Advanced anhydrous catalytic method for high-purity silane coupling agents. Reduces waste and improves yield for reliable supply chain integration.
Patent CN115948356B reveals high-efficiency carbonyl reductase mutants for lipoic acid intermediates, offering supply chain stability and cost reduction.
Novel sodium tert-butoxide catalyzed route offers high yield and mild conditions for scalable pharmaceutical intermediate manufacturing and significant cost efficiency gains.